JGM stem cells, the last of which can be obtained from fetal tissues, including amniotic fluid [5] .
Introduction
Stem cells have the ability to self-renew by producing equipotent progeny and to differentiate into a variety of cell types that make up each organ in the human body [1] . These stem cell properties have been studied for their application to repair damaged areas and injured tissues within the body [2] [3] [4] . Stem cells are generally divided into embryonic, adult, and fetal population with a range of morphologies [7] . Amniotic fluidderived stem cells (AFSCs) were first isolated on the basis of their ability to adhere to plastic, and were characterized by their expression of mesenchymal cell surface markers (CD90 and CD105), a pluripotent marker (Oct-4), and an embryonic stem cell (ESC)-specific marker (stage-specific embryonic antigen-4 [8, 9] .
AFSCs can be expanded and differentiated into adipocytes, osteocytes, and myocytes, as well as endothelial, hepatic, and neurogenic cells [2] . In addition, AFSCs have a high proliferative capacity and can be transplanted autologously without immunity-related problems and the ethical concerns associated with the use of ESCs. Furthermore, AFSCs do not form tumors in severe combined immunodeficient mice [2] . Implanted AFSCs can survive and migrate into the striatum of normal and ischemic rats, and express doublecortin, a marker for immature neurons at 10 days, and glial fibrillary acidic protein (GFAP), a marker for astrocytes at 10, 30, and 90 days after transplantation [3] . These findings suggest that AFSCs could be a new cell source in therapies for nervous system pathologies in the future.
As a signaling molecule, the vitamin A derivative retinoic acid (RA) is involved in neuronal patterning and neural differentiation, and plays a role in generating specific neuronal cell types for therapeutic transplantation and in regenerating axons after damage [10] . RA is especially able to induce the differentiation of ESCs and embryonic carcinoma cells into neural cell types according to time and concentration [11, 12] . Therefore, RA can be used as a therapeutic molecule for the induction of axon regeneration and the treatment of neurodegeneration [10] .
Because AFSCs are at an intermediate stage between embryonic and adult stem cells [2] , we tested whether the RA used in neurogenesis of ESCs can also influence the neurogenesis efficiency of AFSCs that express different levels of two representative stem cell markers, Oct-4 and c-kit. Cells treated with RA were compared with cells treated with a neural induction cocktail containing 3-isobutyl-1-methylxanthine (IBMX), indomethacin, and insulin, which had previously induced adult stem cells from adipose tissue-derived stem cells (ADSCs) into having the morphology of neural cells and expressing neural markers.
Materials and Methods

Isolation and culture of AFSCs
Amniotic fluid was obtained by amniocentesis during the second trimester of gestation, and 18 AFSC types were isolated by the method of Kim et al. [13] . The Institutional Review Board of Kangbuk Samsung Hospital (Seoul, Korea) approved this study (IRB No. C0752).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total cellular RNA was extracted from the cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. The extracted total RNA was reverse-transcribed into first-strand cDNA using oligo-dT primers (Invitrogen) with moloney murine leukemia virus (MMLV) reverse transcriptase, RNasin ribonuclease inhibitor, 5× reaction buffer (Promega, Madison, WI, USA), and 2.5 mM dNTP (Takara, Japan) for 90 min at 37 The cDNA was amplified with 35 cycles of PCR using Taq polymerase (Takara). All primer pairs used for the PCR amplification are described in Table 1 .
Neurogenic differentiation
Cells were plated in control medium in a 6-well dish. After 2 days, the medium was changed to one of three kinds of 
Immunofluorescence
Cells, grown on coverslips in each medium described above, were fixed for 10 min in 4% paraformaldehyde (Junsei Chemical Co. Ltd., Tokyo, Japan) in Dulbecco's modified phosphatebuffered saline (DPBS) at room temperature, and washed with 0.1% bovine serum albumin (BSA; Bovogen, Melbourne, VIC, Australia) in DPBS. This was followed by a 45 min incubation in blocking buffer (10% normal goat serum [Gibco, Grand Island, NY, USA] and 0.3% Triton X-100 [Sigma] in DPBS) at room temperature. The cells were then stained with a primary antibody at 4 o C overnight, washed with 0.1% BSA-containing DPBS, and incubated with fluorescence-labeled secondary antibody at room temperature for 1.5 hours. Then, the cells were washed and counterstained with 0.1 µg/mL 4',6-diamino-2'-phenylindole (Pierce, Rockford, IL, USA). Anti-GFAP (1:400; Dako, Glostrup, Denmark) and anti-Tuj1 (1:500; R&D Systems, Minneapolis, MN, USA) were used as primary antibodies, and Alexa Fluor Ⓡ 488 donkey anti-rabbit immunoglobulin G (IgG) (H+L, 1:400; Invitrogen) and Cy3-goat anti-mouse IgG (1:400; Jackson Immunoresearch Laboratories Inc., West Grove, PA, USA) were used as secondary antibodies.
Results
Stem cell marker expression of AFSCs
With the isolation methods described above, we obtained AFSCs from 18 independent donors. First, the stem cell marker expression levels were examined by performing RT-PCR for Oct-4 and c-kit (Fig. 1) 
Neural differentiation potential of AFSCs
To investigate the effect of RA on neural differentiation of AFSCs expressing different levels of Oct-4 and c-kit, the four selected AFSC samples were treated with three different kinds of neurogenic IM: IM1, IM2, or IM3, as described in Materials and Methods. AFSCs cultured in each of the neurogenic IM began to change their cell morphology within 24 hours. The cytoplasm retracted toward the nucleus, and long and thin cellular processes extended from the cell bodies. After the first day of induction, there were more retracted cells and shorter processes in IM1 than in IM2 and IM3. On the second day of induction, IM2 and IM3 had more morphologically altered cells, which had brightened nuclei, retracted cytoplasm, and developed processes. On the third day of induction, the number of neural-like cells was increased over the previous day in IM2 and IM3, although the cells began to detach from the bottom of the culture dish (Fig. 2) .
We also performed immunostaining and RT-PCR for nervespecific marker expression after 48-72 hours of the induction. The results of immunostaining using the neuronal marker Tuj1 and the astrocyte marker GFAP showed that all four AFSCs in each neurogenic induction medium expressed Tuj1 strongly and GFAP weakly (Fig. 3) . A more extensive RT-PCR analysis was performed for other neural genes (Fig. 4) . For AF1 cells, which induced the expression of NF-M, trkA, and MBP, whereas IM3 had no effect in the expression of neural markers. The summary of these results is displayed as Table 2 and suggests that AFSCs expressing both Oct-4 and c-kit have the greatest potency for neurogenesis, and RA has little effect on the differentiation process. Finally, to investigate whether the inability of RA to affect neurogenesis of AFSCs was due to a difference in retinoic acid receptor (RAR) expression, the expression levels of two RAR isoforms (α and β) were analyzed. The expression of RARα was different in all four individual samples, which ranged from low to high, and was increased in AF16 by IM2 and in AF18 by IM1 and IM2. The expression of RARβ was low in AF1 and high in the other cells, and was increased in AF1 by all of the IM, and decreased in AF16 and AF17 by IM2 (Fig. 4) . These results indicate that there was no correlation of RAR with RA effects on the expression of neural markers, implying that the lack of effects by RA on neurogenesis of AFSCs was not due to RAR expression.
Discussion
Oct-4 is an important transcription factor as a marker of pluripotent stem cells to maintain the totipotency of ESCs, which disappears rapidly when cells have differentiated [14] . The protein-tyrosine kinase c-kit is also a stem cell-specific factor that is important in gametogenesis, melanogenesis, and hematopoiesis [15] , and is present on human ESCs and primordial germ cells as well as many somatic stem cells [16] [17] [18] . Previous reports have shown that Oct-4 messenger RNA (mRNA) expression is low and Oct-4-positive cells are very weak in amniotic fluid [19, 20] , and c-kit expression was detected in about 1% of cultured amniotic fluid cell populations [2] . In our study, the levels of Oct-4 and c-kit mRNA expression in the AFSCs showed variability sample by sample, as Oct-4 mRNAs were positive in 17 of 18 AFSC samples and c-kit mRNAs were expressed in 11 of 18 AFSC samples (Fig. 1) . We hypothesized that the different expression levels of Oct-4 and c-kit might be caused by either different initial populations of stem/progenitor cells or different cell concentrations. Further studies will be needed to evaluate individual differences of the isolated AFSCs.
In this study, we attempted to evaluate three different kinds of neurogenesis-inducing media, composed of RA and/or neuromix, for neurogenesis of AFSCs. RA is known to affect neurons in ESCs and umbilical cord blood cells at various stages of differentiation, including causing the outgrowth of more and longer neurites than would normally be observed [21] and inducing changes in cell morphology and the expression of RARs as well as neural-specific markers [22] . Neuromix, composed of IBMX, indomethacin, and insulin, was used in the neuronal differentiation of ADSCs. With neuromix, about 20-25% of the ADSCs were differentiated into cells with typical neural morphological characteristics, accompanied by increased expression of NSE, vimentin, and the nerve growth factor receptor trkA [23] . IBMX, a phosphodiesterase inhibitor, causes the elevation of intracellular cyclic adenosine monophosphate (cAMP), which is a neural stimulus for various cell types, including mesenchymal stem cells (MSCs) [24] . Indomethacin, an inhibitor of cyclooxygenase, promotes neural cell survival after ischemic injury in the central nervous system [25] . Insulin promotes the maturation of differentiating neocortical cells in rat brains [26] . Our neurogenesis results, using the three different combinations of neural IM, showed that the AFSCs had similar morphological changes and immunofluorescent staining results, irrespective of their Oct-4 and c-kit expression (Figs. 2 and 3 ), but had different mRNA expression profiles (Fig. 4) . The cell morphology changed according to neuronal induction, where neuromix was more effective than RA. In the RT-PCR results, the number of upregulated neural markers was increased by the neuromix-containing IM but not by the medium containing RA only. RARα and RARβ, the two RAR receptor isoforms, were expressed differently in each induction group of AFSCs. RARα/ β are known to be upregulated in human cord blood-derived CD133 + hematopoietic stem cells when undergoing neuronal induction [22] ; however, this was not seen in the AFSCs in this study. It seems that RA and neuromix did not significantly affect the expression of RAR α/β during neuronal induction of AFSCs. Taking the cell morphology changes and RT-PCR results together, RA had little influence on AFSCs as compared with neuromix; thereby, there were few morphological changes and low mRNA expression of neural cell-specific markers. The result that neuromix is more effective than RA at inducing neuronal differentiation of AFSCs, even though our IM had other ingredients (e.g., indomethacin and insulin), is similar to that seen in placenta-derived multipotent cells (PDMCs) and MSCs derived from human umbilical cord blood (MSC hUCB ) [24, 27] .
Accordingly, the improved effect seen with neuromix in AFSCs might show that these cells are more similar to MSCs, such as PDMCs and MSC hUCB , than ESCs. Therefore, the efficiency of neuronal induction in AFSCs could be different according to the ingredients used in the IM. Oct-4-and c-kit-positive cells also showed much more upregulated neural markers than c-kit-low or -negative cells. Therefore, we hypothesized that c-kit expression, rather than Oct-4 expression, affects neural marker expression in neurogenesis of AFSCs (Table 2) . C-kit is expressed in the nervous system and in nervous system tumors [28] , and stem cell factor to c-kit signaling has a role in neural development [29] . Furthermore, Das et al. [30] reported that c-kit was related to Notch signaling in differentiation in a variety of tissues, including those of the central nervous system. Therefore, c-kit expression might be related to neural differentiation of AFSCs, and its mechanism should be studied further.
There are limited data and methods relevant to the differentiation of stem cells into specialized cell types in vitro or in vivo (at cell transplantation). Although our study demonstrates that AFSCs can change morphologically into neural-like cells and induce cells to express neural markers, further elucidation of the molecular mechanisms involved is needed to decrease the individual differences of isolated AFSCs and increase the efficiency of neural differentiation for therapeutic applications. Further mechanistic insights into neurogenesis in vitro with high efficiency might promote the generation of functionally appropriate neural cells in the future that could be used in cell therapies for neurodegenerative diseases.
